Article: Pipeline a Bit Early on Alexza - Analyst Blog

Pipeline a Bit Early on Alexza - Analyst Blog

Alexza Pharmaceuticals, Inc. ( ALXA ) focuses on the development and commercialization of proprietary products for the treatment of acute and intermittent conditions. We are enthusiastic on the company's proprietary novel Staccato system that reformulates oral or injectable small molecule compounds into an inhalable aerosol.

The company has six product candidates in clinical stage trials, including leading candidates AZ-001 for migraine headache pain relief and AZ-004 for acute agitation in patients with schizophrenia. Recent ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!